Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI.
You Jeong KiBong Ki LeeKyung Woo ParkJang-Whan BaeDoyeon HwangJeehoon KangJung-Kyu HanHan Mo YangHyun-Jae KangBon-Kwon KooDong-Bin KimSi-Hyuck KangKeon Woong MoonHyun Woong ParkKi-Bum WonDong Woon JeonKyoo Rok HanSi Wan ChoiJae Kean RyuYoungkeun AhnKwang Soo ChaHyo-Soo Kimnull nullPublished in: Korean circulation journal (2021)
Prasugrel dose de-escalation reduced the rate of NACE and bleeding, without increasing the rate of ischemic events in NSTE-ACS patients but not in STEMI patients.
Keyphrases
- percutaneous coronary intervention
- antiplatelet therapy
- acute coronary syndrome
- st segment elevation myocardial infarction
- end stage renal disease
- st elevation myocardial infarction
- acute myocardial infarction
- chronic kidney disease
- coronary artery disease
- ejection fraction
- coronary artery bypass grafting
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- atrial fibrillation
- randomized controlled trial
- clinical trial
- patient reported outcomes
- heart failure
- cerebral ischemia